Atlas Trials

A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque Psoriasis

Clinical trial NCT03710681 · UNKNOWN

Trial details

NCT number
NCT03710681
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Moderate-to-severe Plaque Psoriasis
Start date
2018-08-02
Primary completion
2019-04-21
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.